Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorZhu, Y
dc.contributor.authorHarrison, D J
dc.contributor.authorBader, S A
dc.date.accessioned2015-03-16T11:31:02Z
dc.date.available2015-03-16T11:31:02Z
dc.date.issued2004-05-17
dc.identifier173402667
dc.identifier1fbaf97c-061b-4b89-844e-bfa58ff94637
dc.identifier2942622687
dc.identifier.citationZhu , Y , Harrison , D J & Bader , S A 2004 , ' Genetic and epigenetic analyses of MBD3 in colon and lung cancer ' , British Journal of Cancer , vol. 90 , no. 10 , pp. 1972-1975 . https://doi.org/10.1038/sj.bjc.6601776en
dc.identifier.issn0007-0920
dc.identifier.otherRIS: urn:09E8A79DD7B98203AC54218A436BA018
dc.identifier.otherORCID: /0000-0001-9041-9988/work/64034221
dc.identifier.urihttps://hdl.handle.net/10023/6243
dc.description.abstractMBD3: is a member of the methyl-CpG-binding domain family and is located on chromosome 19p13.3, a region of loss of heterozygosity in colon and lung cancers. We therefore screened samples for abnormalities in MBD3. Our results indicate that MBD3 is not a major target of genetic and epigenetic alteration in these cancers.
dc.format.extent4
dc.format.extent103699
dc.language.isoeng
dc.relation.ispartofBritish Journal of Canceren
dc.subjectMBD3en
dc.subjectColon canceren
dc.subjectLung canceren
dc.subjectMutationen
dc.subjectMethylationen
dc.subjectR Medicineen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccRen
dc.subject.lccRC0254en
dc.titleGenetic and epigenetic analyses of MBD3 in colon and lung canceren
dc.typeJournal articleen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.identifier.doi10.1038/sj.bjc.6601776
dc.description.statusPeer revieweden
dc.identifier.urlhttp://www.nature.com/bjc/journal/v90/n10/full/6601776a.htmlen


This item appears in the following Collection(s)

Show simple item record